chitosan has been researched along with pentamidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, JL; de Koning, HP; Garcia-Salcedo, JA; Hernández-Quero, J; Maceira, J; Magez, S; Muñóz-Torres, M; Ortiz-González, M; Soriano, M; Unciti-Broceta, JD | 1 |
| Cantù, L; Carafa, M; Del Favero, E; Esposito, G; Gigli, S; Hanieh, PN; Marianecci, C; Pesce, M; Rinaldi, F; Sarnelli, G; Seguella, L | 1 |
| Ahmad, B; Ahmad, M; Ali, A; Bilal, H; Iqbal, A; Khan, IU; Khan, M; Khan, RU; Rahman, MU; Said, A; Sohail, A; Tariq, A; Ullah, R; Ullah, S; Zaman, A | 1 |
3 other study(ies) available for chitosan and pentamidine
| Article | Year |
|---|---|
Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis.
Topics: Animals; Antibodies, Protozoan; Chitosan; Disease Models, Animal; Drug Carriers; Drug Resistance; Electrophoretic Mobility Shift Assay; Female; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanoparticles; Pentamidine; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosomiasis, African | 2015 |
inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice.
Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Brain; Chitosan; Dopamine; Drug Liberation; Liposomes; Male; Mice, Inbred C57BL; Nasal Mucosa; Parkinsonian Disorders; Pentamidine | 2019 |
Efficacy of pentamidine-loaded chitosan nanoparticles as a novel drug delivery system for Leishmania tropica.
Topics: Animals; Antiprotozoal Agents; Chitosan; Drug Delivery Systems; Humans; Leishmania tropica; Nanoparticles; Pentamidine | 2022 |